397 related articles for article (PubMed ID: 22751450)
21. Arsenic trioxide induces apoptosis in human platelets via C-Jun NH2-terminal kinase activation.
Wu Y; Dai J; Zhang W; Yan R; Zhang Y; Ruan C; Dai K
PLoS One; 2014; 9(1):e86445. PubMed ID: 24466103
[TBL] [Abstract][Full Text] [Related]
22. Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide.
Tan Y; Bi L; Zhang P; Wang F; Lin F; Ni W; Wu J; Jiang L
Int J Clin Exp Pathol; 2014; 7(8):4765-73. PubMed ID: 25197347
[TBL] [Abstract][Full Text] [Related]
23. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
Ozpolat B; Akar U; Zorrilla-Calancha I; Vivas-Mejia P; Acevedo-Alvarez M; Lopez-Berestein G
Apoptosis; 2008 Jul; 13(7):915-28. PubMed ID: 18491231
[TBL] [Abstract][Full Text] [Related]
24. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
25. Peroxiredoxin 3 Has Important Roles on Arsenic Trioxide Induced Apoptosis in Human Acute Promyelocytic Leukemia Cell Line via Hyperoxidation of Mitochondrial Specific Reactive Oxygen Species.
Mun YC; Ahn JY; Yoo ES; Lee KE; Nam EM; Huh J; Woo HA; Rhee SG; Seong CM
Mol Cells; 2020 Sep; 43(9):813-820. PubMed ID: 32975211
[TBL] [Abstract][Full Text] [Related]
26. Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts.
Iriyama N; Yuan B; Yoshino Y; Hatta Y; Horikoshi A; Aizawa S; Takeuchi J; Toyoda H
Oncol Rep; 2013 Jun; 29(6):2362-8. PubMed ID: 23563754
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.
Jing Y; Dai J; Chalmers-Redman RM; Tatton WG; Waxman S
Blood; 1999 Sep; 94(6):2102-11. PubMed ID: 10477740
[TBL] [Abstract][Full Text] [Related]
28. The organic arsenic derivative GMZ27 induces PML-RARα-independent apoptosis in myeloid leukemia cells.
Cheng X; Quintás-Cardama A; Golemovic M; Zingaro R; Gao MZ; Freireich EJ; Andreeff M; Kantarjian HM; Verstovsek S
Anticancer Res; 2012 Jul; 32(7):2871-80. PubMed ID: 22753750
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
30. Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Bornhauser BC; Bonapace L; Lindholm D; Martinez R; Cario G; Schrappe M; Niggli FK; Schäfer BW; Bourquin JP
Blood; 2007 Sep; 110(6):2084-91. PubMed ID: 17537996
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
[TBL] [Abstract][Full Text] [Related]
32. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
[TBL] [Abstract][Full Text] [Related]
33. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
34. The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.
Wang B; Ni Z; Dai X; Qin L; Li X; Xu L; Lian J; He F
Mol Cancer; 2014 Apr; 13():98. PubMed ID: 24779770
[TBL] [Abstract][Full Text] [Related]
35. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
36. Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.
Ding Q; He X; Xia W; Hsu JM; Chen CT; Li LY; Lee DF; Yang JY; Xie X; Liu JC; Hung MC
Cancer Res; 2007 May; 67(10):4564-71. PubMed ID: 17495324
[TBL] [Abstract][Full Text] [Related]
37. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
[TBL] [Abstract][Full Text] [Related]
38. Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1.
Shinohara M; Ybanez MD; Win S; Than TA; Jain S; Gaarde WA; Han D; Kaplowitz N
J Biol Chem; 2010 Mar; 285(11):8244-55. PubMed ID: 20061376
[TBL] [Abstract][Full Text] [Related]
39. Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.
Yedjou C; Tchounwou P; Jenkins J; McMurray R
J Hematol Oncol; 2010 Aug; 3():28. PubMed ID: 20796291
[TBL] [Abstract][Full Text] [Related]
40. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
